Trial Profile
A Randomized, Two-Way Crossover, Multicenter, Consumer Preference Study of Two Oral Formulations of Phenylephrine Hydrochloride.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Apr 2015
Price :
$35
*
At a glance
- Drugs Phenylephrine (Primary)
- Indications Seasonal allergic rhinitis
- Focus Therapeutic Use
- Sponsors Schering-Plough
- 04 Mar 2013 Actual end date changed from Dec 2009 to Nov 2009 as reported by ClinicalTrials.gov.
- 12 Dec 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 18 Sep 2009 New trial record